RECHERCHE :   Tumeurs du système nerveux
Filtrage ? Le champ de filtrage permet de trier les études comportant le mot saisie. La recherche du mot se fait uniquement dans le contenu texte affiché à l'écran.
ETUDE PHASE SITE
AG-881-C-004: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-Controlled Study of AG-881 in Subjects With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation
Gliome
III
CHUV
ROAM/EORTC-1308: Radiation versus Observation following surgical resection of Atypical Meningioma: a randomised controlled trial (The ROAM trial)
Méningiome
autre
CHUV
EORTC 1635-BTG: IDH mutated 1p/19q intact lower grade glioma following resection: Wait Or Treat? IWOT - A phase III study
Gliome de bas grade avec mutation IDH sans codélétion 1p/19q
III
CHUV
IMA950-106 - Pembrolizumab in association with the Multipeptide vaccine IMA950 adjuvanted with Poly-ICLC for relapsing Glioblastoma: a randomized phase I/ II trial
Relapsing Glioblastoma
I, II
HUG
INDIGO/AG881-C-004: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-Controlled Study of AG-881 in Subjects With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation
Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation
III
CHUV, HUG
PH-L19TNFGLIO-02/18 - A study to evaluate the safety and efficacy of the tumor-targeting human antibody-cytokine fusion protein L19TNF in patients with isocitrate dehydrogenase (IDH) wildtype WHO grade III / IV glioma at first relapse
grade III / IV glioma
I, II
CHUV
RESURGE: Randomized Controlled Comparative Phase II Trial on Surgery for Glioblastoma Recurrence
Gliobastome récidivant
II
CHUV